Forvis Mazars Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Sell
4,259
-18
-0.4% -$1.7K 0.01% 339
2026
Q2
$368K Sell
4,277
-20
-0.5% -$1.75K 0.01% 347
2026
Q1
$389K Buy
4,297
+20
+0.5% +$1.84K 0.01% 321
2025
Q4
$385K Sell
4,277
-46
-1% -$4.36K 0.01% 318
2025
Q3
$426K Sell
4,323
-7
-0.2% -$694 0.01% 309
2025
Q2
$395K Buy
4,330
+14
+0.3% +$1.35K 0.01% 325
2025
Q1
$488K Buy
+4,316
New +$462K 0.01% 286
2024
Q3
– Sell
-4,488
Closed -$487K – 443
2024
Q2
$487K Buy
+4,488
New +$529K 0.01% 296

Other funds holding ZBH

Forvis Mazars Wealth Advisors's ZBH Position: Q3 2026 in Review

Forvis Mazars Wealth Advisors reduced its Zimmer Biomet (ZBH) stake by 0.42% in Q3 2026, selling an estimated $1.7K and leaving 4,259 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #339.

Forvis Mazars Wealth Advisors first reported a position in ZBH in Q2 2024 and has held it in 8 quarters since. The position peaked at $488K in Q1 2025. 936 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Forvis Mazars Wealth Advisors held 4,259 shares of Zimmer Biomet worth $378K as of Q3 2026.
  • Forvis Mazars Wealth Advisors sold 18 Zimmer Biomet shares in Q3 2026, an estimated $1.7K.
  • Zimmer Biomet made up 0.01% of Forvis Mazars Wealth Advisors's portfolio in Q3 2026, its #339 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Zimmer Biomet in Q2 2024 and has held it in 8 quarters since.
  • Forvis Mazars Wealth Advisors's Zimmer Biomet position peaked at $488K in Q1 2025.
  • 936 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.